AVTE · Aerovate Therapeutics
Acquired Company
Jade Biosciences completed the merger with Aerovate Therapeutics on 4/28/2025.
Aerovate Therapeutics, Inc., a biopharmaceutical company, engages in the treatment of pulmonary arterial hypertension in the United States. Aerovate Therapeutics, Inc., was incorporated in 2018 and is headquartered in Waltham, Massachusetts.
Market Cap
77.68M
52 Wk Range
$2.63 - $884.98
Previous Close
$14.00
Open
$14.00
Volume
1,329,063
Day Range
$13.35 - $14.24
Enterprise Value
1.782M
Cash
76.21M
Avg Qtr Burn
-12.48M
Insider Ownership
0.02%
Institutional Own.
N/A
Qtr Updated
Mar 31st 2025